Position in ABUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,204,352
+$88,691 QoQ
Shares Held
250,907
+1.2% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 175 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. ABUS ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ABUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,204,352 | 250,907 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,115,661 | 247,925 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,189,290 | 247,254 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $951,754 | 209,638 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $559,547 | 181,084 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $486,720 | 139,462 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $228,345 | 69,831 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $254,295 | 66,051 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $188,881 | 61,127 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $153,606 | 59,538 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $141,682 | 56,673 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $114,927 | 56,615 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $123,142 | 53,540 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $142,273 | 46,955 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $105,686 | 45,359 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $72,512 | 37,965 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $94,958 | 35,040 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $80,155 | 26,898 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $98,747 | 25,385 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,181 | 29,180 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $76,313 | 25,186 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||